Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Dixie7777 who wrote (2624)	7/6/1998 1:26:00 PM
From: Jim B	Respond to of 5402

good questions.. make suer PROSPECTOR gets them.. as you posted to me. jim

To: Dixie7777 who wrote (2624)	7/6/1998 1:57:00 PM
From: drdan	Read Replies (1) \| Respond to of 5402

Rich, just a comment on your question #4....I think that if someone asks it that way, he'll just say no comment or something vague....try saying "where will financing come once the initial funding is depleted" and he might say a bit more, either thru body language or verbally.Does that sound good to you?

To: Dixie7777 who wrote (2624)	7/17/1998 5:17:00 PM
From: Prospector	Respond to of 5402

ou are responding to this message from Dixie7777 on Jul 6 1998 1:09PM EST Questions; 1. Are there any large shareholders that could be classified as ...."institutional?" We are negotiating with some. Will announce when deal is done... 2. If so, how many shares do they currently hold? ZERO 3. Can we get VERY accurate numbers regards the shares; ....Authorized 100,000,000 ....Issued 22,000,000 ....In the float 3,800,000 ....Publicly traded in the float 4. Has there been any contact of SGNC by any, ANY pharmaceutical company Many pharmaceutical firms including Abbott, Merck, Pfizer, etc.